Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-508-0 | CAS number: 3126-80-5
PBT assessment
Administrative data
PBT assessment: overall result
- Name:
- Lexolube1
- Type of composition:
- legal entity composition of the substance
- State / form:
- liquid
- Reference substance:
- Lexolube1
- PBT status:
- the substance is not PBT / vPvB
- Justification:
Criteria for assessing PBT properties are defined in Annex XIII, REACH Regulation (EC) No 1907/2006. Further details are laid down in ECHA Guidance on Information Requirements and Chemical Safety Assessment; Chapter R.11: PBT Assessment (Nov 2014). The assessment of PBT / vPvB properties is based upon a separate assessment for each parameter (i.e. P or vP, B or B and T). Substances are only assigned as PBT or vPvB when they fulfil the criteria for all three properties (persistency, bioaccumulation and toxicity in case of PBT substance) or both criteria (i.e. very persistent and very bioaccumulative) in case of vPvB, respectively.
Available data indicate that the substance does not meet the requirements for B and T classification. Even though the substance is not readily biodegradable (possibly P) degradation does occur. Modelling of possible degradation pathways does indicate that ultimate degradation is feasible, predicting likely degradation products that are known to be readily biodegradable.
Therefore, making all allowances for regulatory parameters available, the substance is neither PBT nor vPvB.
- Likely routes of exposure:
Workers may be exposed via the dermal route due to substance handling during manufacture. This exposure is negligible as the absorption through the skin is nearly zero. Based on the low vapour pressure of the substance, an uptake via the inhalative route is not relevant, too. Oral exposure is not relevant based on the handling, education and safety precautions in the factory. As conclusion, only the dermal exposure route may be relevant for humans, but is negligible.
Reference
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
